Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Palatin and King initiate trial in female sexual arousal disorder
The clinical trial, which will enroll approximately 60 patients, is designed to evaluate the safety and efficacy of PT-141 in the “at-home” environment. It will entail a two
The clinical trial, which will enroll approximately 60 patients, is designed to evaluate the safety and efficacy of PT-141 in the “at-home” environment. It will entail a two
According to the company, infection with CMV, a member of the herpes virus group, averages between 50% and 85% of adults in the US by 40 years of
The company has selected Hong Kong-based South Asia Pharmamedic as its distribution partner in the People’s Republic of China and Hong Kong to help sell the pain relief
This was the third of several regularly scheduled reviews by the data safety monitoring board (DSMB) that will occur over the duration of the trial, in order to
The 28-day, phase II clinical study enrolled 12 treatment-naive patients with genotype 1 HCV. Patients received VX-950 in a tablet formulation at a dose of 750 mg every
The company will instead focus its resources on Invirase, a tablet formulation of the drug that offers a more convenient and tolerable treatment regimen for HIV positive patients.
The vaccine candidate is based on HIV subtype C, the most prevalent subtype of the virus in southern and eastern Africa, and was developed by Seattle based Targeted
The trial, the first study of bicifadine in patients with neuropathic pain, will randomize 50 patients with painful diabetic neuropathy into two parallel four-week treatment groups. The trial
This second study will compare the treatment of dexamethasone with Xerecept in patients already on low-dose steroid whose dose must be escalated to treat their symptoms. In November
The compounds, known as Ceragenins (CSAs), were invented and developed at Brigham Young University, and Vanderbilt University, before being licensed to Ceragenix. “We are encouraged, based on these